Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Hoare

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Peptides|May 7, 2004
Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligandsSam R J Hoare, Susan K Sullivan, Anil Pahuja, et al.
Frontiers in Cellular Neuroscience|February 3, 2022
Quantifying the Kinetics of Signaling and Arrestin Recruitment by Nervous System G-Protein Coupled ReceptorsSam R J Hoare, Paul H Tewson, Shivani Sachdev, et al.
Biochemical Pharmacology|June 6, 2006
Single amino acid residue determinants of non-peptide antagonist binding to the corticotropin-releasing factor1 (CRF1) receptorSam R J Hoare, Brock T Brown, Mark A Santos, et al.
Molecular Pharmacology|February 2, 2008
Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activationSam R J Hoare, Beth A Fleck, Raymond S Gross, et al.
The Journal of Biological Chemistry|January 18, 2005
Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulatedStephen J Perry, Sachiko Junger, Trudy A Kohout, et al.
Biochemistry|November 3, 2005
Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptorBeth A Fleck, Chen Chen, Weidong Yang, et al.
Biochemistry|March 31, 2004
Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonistsSam R J Hoare, Sue K Sullivan, David A Schwarz, et al.
Biochemical Pharmacology|August 26, 2006
Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonismSusan K Sullivan, Sam R J Hoare, Beth A Fleck, et al.
Endocrinology|March 19, 2005
The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule melanocortin-4 receptor antagonistStacy Markison, Alan C Foster, Chen Chen, et al.
Cellular and Molecular Life Sciences : CMLS|March 30, 2026
Intracellular and dual-site inhibition of a bitter taste GPCRNitsan Dallal, Gil Daniel Paz, Noga Nir-Marom, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Peptides|May 7, 2004
Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligandsSam R J Hoare, Susan K Sullivan, Anil Pahuja, et al.
Frontiers in Cellular Neuroscience|February 3, 2022
Quantifying the Kinetics of Signaling and Arrestin Recruitment by Nervous System G-Protein Coupled ReceptorsSam R J Hoare, Paul H Tewson, Shivani Sachdev, et al.
Biochemical Pharmacology|June 6, 2006
Single amino acid residue determinants of non-peptide antagonist binding to the corticotropin-releasing factor1 (CRF1) receptorSam R J Hoare, Brock T Brown, Mark A Santos, et al.
Molecular Pharmacology|February 2, 2008
Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activationSam R J Hoare, Beth A Fleck, Raymond S Gross, et al.
The Journal of Biological Chemistry|January 18, 2005
Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulatedStephen J Perry, Sachiko Junger, Trudy A Kohout, et al.
Biochemistry|November 3, 2005
Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptorBeth A Fleck, Chen Chen, Weidong Yang, et al.
Biochemistry|March 31, 2004
Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonistsSam R J Hoare, Sue K Sullivan, David A Schwarz, et al.
Biochemical Pharmacology|August 26, 2006
Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonismSusan K Sullivan, Sam R J Hoare, Beth A Fleck, et al.
Endocrinology|March 19, 2005
The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule melanocortin-4 receptor antagonistStacy Markison, Alan C Foster, Chen Chen, et al.
Cellular and Molecular Life Sciences : CMLS|March 30, 2026
Intracellular and dual-site inhibition of a bitter taste GPCRNitsan Dallal, Gil Daniel Paz, Noga Nir-Marom, et al.
Pageof 8